INSTITUTO DE PATOLOGIA RETINIANA SLP
Company details
- Active NIF/CIF: B54440771
-
-
-
-
Address: Calle Atún, 26, 03540 Alicante, Alicante, España See in map
-
-
Featured products:
More information on INSTITUTO DE PATOLOGIA RETINIANA SLP
-
09/08/2011 | BORME act no.: 258625 | Register: ALICANTEDepósito de cuentas anuales (Julio de 2011)
-
09/09/2010 | BORME act no.: 492268 | Register: ALICANTEDepósito de cuentas anuales (Agosto de 2010)
-
06/10/2009 | BORME act no.: 419680 | Register: ALICANTEConstitución
-
06/10/2009 | BORME act no.: 419680 | Register: ALICANTENombramientos
Other information
The CIF assigned to INSTITUTO DE PATOLOGIA RETINIANA SLP is B54440771, while its current business status is active. The company operates in the economic sector identified by the CNAE 8622 - Specialised medicine activities. In addition, its activity corresponds to the SIC classification 8069 - Hospitales especializados.
The template of INSTITUTO DE PATOLOGIA RETINIANA SLP includes Between 10 and 49 employees, and the company reports an annual turnover of less than 2 million euros. INSTITUTO DE PATOLOGIA RETINIANA SLP is registered in the Mercantile Registry of Alicante and accumulates a total of 2 registration charges. The most recent announcement in Borme was published on 09/08/2011, while its last deposit of ordinary annual accounts is related to the 2023 exercise.
If you want to obtain contact information for INSTITUTO DE PATOLOGIA RETINIANA SLP, such as the telephone number, postal address, or website, you can consult our Company Data module.
To access more details about INSTITUTO DE PATOLOGIA RETINIANA SLP, consider reviewing one of our available financial reports, the company's Annual Accounts, or verifying its outstanding payments registered in the RAI delinquency file.
The financial, commercial, and legal information provided about INSTITUTO DE PATOLOGIA RETINIANA SLP comes from official data sources and is automatically updated every day.
Do you want to know more about INSTITUTO DE PATOLOGIA RETINIANA SLP??
Find out more about this company by consulting these reports: